Topic: Mechanisms of Drug Resistance and Combination Therapy in Lung Cancer Targeted Treatment

The emergence of drug resistance poses a formidable challenge in the battle against lung cancer, jeopardizing the hard-won gains achieved through targeted therapies. Understanding the intricate mechanisms underpinning drug resistance and developing innovative strategies to overcome it have become focal points in contemporary oncology research.

This Special Issue, titled "Mechanisms of Drug Resistance and Combination Therapy in Lung Cancer Targeted Treatment", seeks to delve deep into the multifaceted landscape of drug resistance mechanisms and explore novel approaches that harness the power of combination therapy to counteract resistance. By assembling a diverse array of research findings, cutting-edge insights, and expert perspectives, this Special Issue aims to illuminate the path forward in the relentless pursuit of effective lung cancer treatment.

Proposed topics include but are not limited to:
● Mechanisms of innate and acquired drug resistance;
● Biomarkers for predicting drug response;
● Overcoming resistance through novel agents;
● The role of liquid biopsy in tracking molecular resistance;
● The role of preclinical models in investigating new drug combinations;
   etc.

15 Nov 2024